City
Epaper

Odisha registers single-day record 755 corona cases

By IANS | Updated: July 10, 2020 11:55 IST

Bhubaneswar, July 10 Odisha reported four COVID-19 deaths and 755 new positive cases, the highest single-day spike in ...

Open in App

Bhubaneswar, July 10 Odisha reported four COVID-19 deaths and 755 new positive cases, the highest single-day spike in the state, in the last 24 hours, the Health Department said on Friday.

With this, the total positive cases increased to 11,956 while the death toll reached 56.

All the four deaths were in Ganjam district a 41-year-old male suffering from hypertension, a 58-year-old male, a 48-year-old male suffering from diabetes, and a 32-year-old male also suffering from diabetes.

The maximum 320 were reported from hotspot Ganjam district, followed by Jajpur with 86 and Sundargarh with 62 cases.

Of the new positive cases, 508 were reported from different quarantine centres and remaining 247 local contacts.

The department said that contact-tracing and follow-up action is underway.

( With inputs from IANS )

Tags: odishaHealth Department
Open in App

Related Stories

NationalOdisha Accident: Five Killed, Several Injured After Bus Overturns in Nayagarh

NationalOdisha Hospital Fire: 10 Patients Dead After Blaze Erupts In Cuttack’s SCB Medical College ICU

NationalOdisha Horror: Drunk Man Kills Wife, Daughter-In-Law, Granddaughter With Hammer Over Domestic Dispute

NationalFive School Staff Arrested in Kendrapara for Alleged Sexual Assault of Minor; Case Registered Under POCSO

NationalOdisha Road Accident: Two Trucks Collide, Catch Fire in Balasore; Drivers Suffer Burn Injuries

Health Realted Stories

HealthMeditation can help find solutions to global challenges: V-P Radhakrishnan

HealthIndia’s pharmaceutical exports exceed $28 billion up to February

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support